BHC Physician Assistant, Provider

Saeed Abbaszedeh is a Physician Assistant at the Bateman Horne Center (BHC). He completed a Bachelor of Science (BS) in psychology with a neurobiology minor in biochemistry at the University of Utah and a master’s in physician assistant studies at the University of Utah School of Medicine. Abbaszedeh has practiced for two decades and has an advanced understanding of chronic pain, addiction management and comorbidities with specialized training in internal medicine, pediatric and adult neurology and now specializes in the diagnosis, treatment, and research related to long COVID, ME/CFS, FM, and related comorbidities.

Abbaszedeh is experienced in clinical research protocols, IRB rules, and evidence-based medicine brings a unique sensitivity and professionalism to his patients and their families. In addition to his work with Jean Brown Research, he has provided services for the Maliheh Free Clinic, Interventional Radiology at the University of Utah Hospital, Adult Neurology & Addiction Medicine with Dr. Joseph Watkins, Pediatric Neurology at the University of Utah & Primary Children’s hospitals, oncology at Huntsman Cancer, and chronic pain management with Summit Pain Clinic. Abbaszedeh is proficient in English, Turkish, Persian, and functional Spanish.

Education and Training

Institution and Location Degree Completion Field of Study
University of Utah, Salt Lake City, Utah BS 2000 Psychology, Neurobiology
University of Utah, School of Medicine, Salt Lake City, Utah MS 2004 Physician Assistant Studies

Personal Statement

I am a dedicated clinician who has been practicing for over 19 years. The greater part of my medical emphasis and training has been in general neurology, both child and adult. I also chose to specialize in chronic pain management, inpatient oncology, interventional radiology and have continued a path as a clinical research sub-investigator. I joined BHC in February of 2021 and to focus on education, diagnosis, treatment, and research specifically involving long COVID, ME/CFS, FM and related comorbidities. I have gained a wealth of experience and knowledge working alongside highly respected physicians and scientists at BHC.

After receiving a Bachelor of Science in neurobiology and psychology and subsequent master’s degree in physician assistant studies at the University of Utah, I gravitated towards diagnosing and treating patients with chronic, disabling multi-system illnesses. My personal overarching clinical goal is to deliver high value, compassionate, and the most progressive care to our patients.

Positions and Honors

2021-PR Physician Assistant, Bateman Horne Center, Salt Lake City, Utah
2019-2021 General Adult and Child Neurology, Maliheh Free Clinic (Volunteer)
2019-2020 Interventional Radiology, University of Utah Hospital
2018-2019 Clinical Research -Investigator– PRN, Jean Brown Research
2017-2018
2004-2008
Adult Neurology & Addiction Medicine, Joseph Watkins, MD
2012-2016 Pediatric Neurology, University of Utah & Primary Children’s
2009-2012 Oncology/Hematology/BMT (Inpatient), Huntsman Cancer Hospital
2008-2009 Chronic Pain Management, Summit Pain Clinic
2004-2008 Adult and Pediatric Neurology,  Utah Neurological Center

  Research Experience

2022-PR

Sub Investigator at Bateman Horne Center for investigator-initiated and industry-sponsored clinical trials involving ME/CFS, Long COVID, and fibromyalgia.

 

  • RESTORE ME: A randomized double-blind, placebo-controlled trial to determine the effects of oxaloacetate on improving fatigue in ME/CFS.
  • REGAIN: A randomized, double-blind, placebo-controlled trial to determine the effects of oxaloacetate on improving fatigue in long COVID.
  • RECOVER AUTONOMIC: A platform for evaluation of interventions for autonomic dysfunction in post-acute sequelae of SARS-CoV_2 infection (PASC).
  • BHC201: An open-label pilot study with the combination of valacyclovir and celecoxib for treatment of post-acute sequelae of SARS-CoV_2 infection in adults.
  • BHC IMC2: A randomized, double-blinded, placebo-controlled pilot study of the combination of valacyclovir and celecoxib (IMC-2) for the treatment of post-acute sequelae of SARS-CoV_2 infection in adults.
  • CSL BEHRING: Double-blind, randomized, placebo-controlled phase 3 study evaluating efficacy and safety of IgPro20 (subcutaneous immunoglobulin, HIZENTRA) in post-COVID-19 postural orthostatic tachycardia syndrome (POTS).
  • VIRIOS: A double-blinded, randomized, placebo-controlled phase 2B trial of IMC-1 for the treatment of fibromyalgia.
  • TONIX RALLY: A phase 3 double-blind, randomized, multicenter, placebo-controlled study to evaluate the efficacy and safety of TNX-102 SL taken daily at bedtime in patients with fibromyalgia.
  • EXAGEN DIAGNOSTICS: Biomarker evaluation for the differential diagnosis and monitoring of fibromyalgia compared to autoimmune rheumatic disease, other pain syndromes, and normal subjects.
  • ENDOPAT UPTIME: Assessment of endothelial function and upright activity in individuals with ME/CFS and long COVID.
  • JAX NIH LONGITUDINAL STUDY:  Topological mapping of immune, microbiota, metabolomic and clinical phenotypes to reveal ME/CFS disease mechanisms.
2020 A Phase I/II, Randomized, Double-blind, Comparator-controlled, Dose-escalation Study to Evaluate the Safety, Pharmacokinetics, and Efficacy of Pregabalin for Postsurgical Pain Management Following Inguinal Hernia Repair
2020 A Randomized, Active-Comparison, Double-Blind, Phase 2 Study to Assess the Safety and Immunogenicity of Anthrax Vaccine

Teaching Experience

2018-2019 Preceptor, Lecturer & Clinical Tutor, Utah Physician Assistant Program
2011-2013 Adjunct Professor, Internal Medicine, Touro University, Nevada
2000-2001 Instructor, Advanced Human Anatomy, University of Utah

Publications

2001 Society for Neuroscience – San Diego
“Differential effects of conotoxin peptides targeting novel voltage-gated sodium, nociceptive C-fibers”

Presentations

2016 Grand Rounds -“Novel Anti-epileptics in Pediatrics”- IHC
2011 Bio-Science Graduate Symposium
Electrophysiological Study: Role of Tetrodotoxin-Resistant Sodium Channels in Nociceptive, Cutaneous Fibers

Certifications and Licensure

  • DEA Suboxone Waiver XA1209964/ MA1209964
  • State of Utah and Controlled Substance License
  • NCCPA- National PA Certification
  • Surgical PA- National Board Certification